ImmunityBio (IBRX) Other financing activities (2014 - 2026)
ImmunityBio (IBRX) posted quarterly Other financing activities of $53.5 million for Q1 2026, up 242.84% quarter-over-quarter from $15.6 million in Q3 2024.
ImmunityBio (IBRX) Other financing activities (2014 - 2026) Analysis & Trends
ImmunityBio (IBRX) has reported Other financing activities for 10 consecutive years, with $53.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other financing activities changed N/A year-over-year to $53.5 million; the TTM figure through Mar 2026 stood at $53.5 million (down 21.7% YoY), while the FY2024 annual figure was $73.3 million, changed N/A from the prior year.
- Other financing activities climbed to $53.5 million in Q1 2026 per IBRX's latest filing, from $15.6 million in the prior quarter.
- Across five years, Other financing activities topped out at $53.5 million in Q1 2026 and bottomed at -$126000.0 in Q2 2023.
- Historically, Other financing activities has averaged $17.0 million across 4 years, with a median of $7.1 million in 2023.
- Annual changes were most pronounced in 2022 — Other financing activities sank 93.4% — and 2024, when it soared 41976.19%.
- ImmunityBio's Other financing activities stood at -$74000.0 in 2022, then slumped by 70.27% to -$126000.0 in 2023, then jumped by 12494.44% to $15.6 million in 2024, then soared by 242.84% to $53.5 million in 2026.
- Business Quant data shows IBRX's Other financing activities at $53.5 million in Q1 2026, $15.6 million in Q3 2024, and $52.8 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | ImmunityBio | 7.97 Bn | 7.62 Bn | 50.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53.54 Mn |
| Mar 31, 2026 | 53.54 Mn |
| Sep 30, 2024 | 15.62 Mn |
| Sep 30, 2024 | 15.62 Mn |
| Jun 30, 2024 | 52.76 Mn |
| Jun 30, 2024 | 52.76 Mn |
| Mar 31, 2024 | 14.12 Mn |
| Mar 31, 2024 | 14.12 Mn |
| Jun 30, 2023 | -126,000.00 |
| Jun 30, 2023 | -126,000.00 |
| Mar 31, 2023 | 126,000.00 |
| Mar 31, 2023 | 126,000.00 |
| Dec 31, 2022 | -74,000.00 |
| Dec 31, 2022 | -74,000.00 |
| Mar 31, 2022 | 74,000.00 |
| Mar 31, 2022 | 74,000.00 |
| Dec 31, 2021 | -371,000.00 |
| Dec 31, 2021 | -371,000.00 |
| Sep 30, 2021 | 1.40 Mn |
| Sep 30, 2021 | 1.40 Mn |